The role of procalcitonin and Clinical Pulmonary for Infection Score (CPIS) score to reduce inappropriate antibiotics use among moderate to severe coronavirus disease 2019 (COVID-19) pneumonia: A quasi-experimental multicenter study

Sathitakorn O.Chansirikarnjana S.Jantarathaneewat K.Weber D.J.Warren D.K.Apisarnthanarak P.Tantiyavarong P.Apisarnthanarak A.Mahidol University2023-08-282023-08-282023-07-22Infection Control and Hospital Epidemiology Vol.44 No.7 (2023) , 1199-12030899823Xhttps://repository.li.mahidol.ac.th/handle/123456789/88864In this quasi-experimental study, implementing a procalcitonin and Clinical Pulmonary Infection Score (CPIS) successfully reduced inappropriate antibiotic use among severely-to-critically ill COVID-19 patients, multidrug-resistant organisms, and invasive fungal infections during the intervention period in 2 medical centers. However, this strategy did not improve inappropriate antibiotic use among mildly-to-moderately ill COVID-19 patients.MedicineThe role of procalcitonin and Clinical Pulmonary for Infection Score (CPIS) score to reduce inappropriate antibiotics use among moderate to severe coronavirus disease 2019 (COVID-19) pneumonia: A quasi-experimental multicenter studyArticleSCOPUS10.1017/ice.2022.2012-s2.0-851643643631559683435993305